Sven Thormahlen

Keine laufenden Positionen mehr

68 Jahre

Consumer Non-Durables

Health Technology

Consumer Services

Ehemalige bekannte Positionen von Sven Thormahlen

Unternehmen	Position	Beginn	Ende
MucoVax GmbH	Vorstandsvorsitzender	-	-
CORBION N.V.	Technik-/Wissenschafts-/F&E-Leiter	12.05.2014	-
L'ORÉAL	Technik-/Wissenschafts-/F&E-Leiter	-	-
L'ORÉAL	Corporate Officer/Principal	-	-
Cerecin, Inc. Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO.	Direktor/Vorstandsmitglied	03.01.2012	-
YAKULT HONSHA CO.,LTD.	Direktor/Vorstandsmitglied	12.01.2010	-
DANONE	Technik-/Wissenschafts-/F&E-Leiter	06.01.2010	-

University of Hamburg

Doctorate Degree

International

Operativ

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	4
DANONE	Consumer Non-Durables
L'ORÉAL	Consumer Non-Durables
CORBION N.V.	Consumer Non-Durables
YAKULT HONSHA CO.,LTD.	Consumer Non-Durables

Private Unternehmen	2
Cerecin, Inc. Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO.	Health Technology
MucoVax GmbH

Private Unternehmen

Health Technology

MucoVax GmbH